Intensive care protocol aims to tame brain hemorrhage in first critical hours
NCT ID NCT06648369
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This trial investigates a 'maximal medical treatment' bundle for people with intracerebral hemorrhage (bleeding in the brain). The bundle includes rapid blood pressure control, reversal of blood thinners, and a drug to reduce bleeding, all delivered within the first 72 hours in a high-dependency unit. The study enrolls adults with non-traumatic brain bleeding within 6 hours of symptom onset and aims to see if this intensive approach is feasible and safe. If it works, it could lead to better outcomes for a condition that currently has limited treatment options.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MAX-ICH care bundle (intensive blood pressure control, anticoagulation reversal, tranexamic acid)
What this could lead to
If successful, this approach could become a standard treatment to reduce disability and death from intracerebral hemorrhage.
What could go wrong
This is a small pilot study focused on feasibility, not yet on proving effectiveness. The intensive protocol may be difficult to implement in all hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRA CEREBRAL HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- REASSESS ICH: Long-Term Cognitive Study (NCT05611918)
- RECONFIG Study: Consciousness After Brain Bleed NCT03990558
- COPITCH Study: Oedema in Brain Hemorrhage Progno NCT04621357
- Brain AVM & Aneurysm Study: Observational Trial NCT07353736
- EVACUATE Trial: Minimally Invasive Brain Bleed S NCT04434807
- Sleep Apnea Treatment in Stroke Rehab (NCT06029959)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Inselspital, University Hospital Bern
RECRUITINGBern, 3010, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••